264 related articles for article (PubMed ID: 24419125)
21. Reference intervals for serum sex hormones in Han Chinese adult men from the Fangchenggang Area Male Health and Examination Survey.
Qin X; Lv H; Mo Z; Chen Z; Lin L; Peng T; Zhang H; Yang X; Gao Y; Tan A; Huang S; Li H; Wu H; Deng Y; Li S
Clin Lab; 2012; 58(3-4):281-90. PubMed ID: 22582502
[TBL] [Abstract][Full Text] [Related]
22. Alterations in hormone levels after adjuvant chemoradiation in male rectal cancer patients.
Yoon FH; Perera F; Fisher B; Stitt L
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1186-90. PubMed ID: 19095371
[TBL] [Abstract][Full Text] [Related]
23. [Serum levels of testosterone, follicie-stimulating hormone and luteinizing hormone in normal human males (author's transl)].
Ruiz E; Ortega E; Sánchez-Cantalejo E; Osorio C
Rev Esp Fisiol; 1977 Sep; 33(3):187-90. PubMed ID: 897322
[TBL] [Abstract][Full Text] [Related]
24. Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors.
Sprauten M; Haugnes HS; Brydøy M; Kiserud C; Tandstad T; Bjøro T; Bjerner J; Cvancarova M; Fosså SD; Oldenburg J
Ann Oncol; 2015 Oct; 26(10):2133-40. PubMed ID: 26265167
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Wichers M; Helmers A; Albers P; Mezger J; Klingmüller D
J Urol; 1998 Jun; 159(6):1942-6. PubMed ID: 9598493
[TBL] [Abstract][Full Text] [Related]
26. Endocrinological late effects after chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schuppert F; Schmoll HJ
Br J Cancer; 1996 May; 73(9):1108-14. PubMed ID: 8624272
[TBL] [Abstract][Full Text] [Related]
27. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
Kobayashi T; Nishizawa K; Mitsumori K
Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
[TBL] [Abstract][Full Text] [Related]
28. Influence of gonadal hormones on endocrine activity of gonadotroph cells in the adenohypophysis of male lambs during the postnatal transition to puberty.
Wańkowska M; Polkowska J; Wójcik-Gładysz A; Romanowicz K
Anim Reprod Sci; 2010 Dec; 122(3-4):342-52. PubMed ID: 21035969
[TBL] [Abstract][Full Text] [Related]
29. Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer.
Yau I; Vuong T; Garant A; Ducruet T; Doran P; Faria S; Liberman S; Richard C; Letellier F; Charlebois P; Loungnarath R; Stein B; Devic S
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1481-6. PubMed ID: 19147304
[TBL] [Abstract][Full Text] [Related]
30. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study.
Hussein A; Ozgok Y; Ross L; Rao P; Niederberger C
BJU Int; 2013 Mar; 111(3 Pt B):E110-4. PubMed ID: 22958644
[TBL] [Abstract][Full Text] [Related]
31. Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio.
Holm M; Rajpert-De Meyts E; Andersson AM; Skakkebaek NE
J Pathol; 2003 Mar; 199(3):378-86. PubMed ID: 12579540
[TBL] [Abstract][Full Text] [Related]
32. The hormonal pattern in alcoholic disease. I. Luteinizing hormone (LH), follicle-stimulating hormone (FSH) and testosterone.
Simionescu L; Oprescu M; Protici M; Dimitriu V
Endocrinologie; 1977; 15(1):45-9. PubMed ID: 557832
[TBL] [Abstract][Full Text] [Related]
33. Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor.
Wiechno PJ; Kowalska M; Kucharz J; Sadowska M; Michalski W; Poniatowska G; Jońska-Gmyrek J; Rzymkowska J; Nietupski K; Demkow T
Med Oncol; 2017 May; 34(5):84. PubMed ID: 28389909
[TBL] [Abstract][Full Text] [Related]
34. Gonadal function in patients with testicular germ cell tumors.
Tomomasa H; Oshio S; Ashizawa Y; Kamiyama Y; Okano Y; Iiyama T; Sato S; Shimizu H; Umeda T
Arch Androl; 2002; 48(6):405-15. PubMed ID: 12425758
[TBL] [Abstract][Full Text] [Related]
35. Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia.
Tsolaki M; Grammaticos P; Karanasou C; Balaris V; Kapoukranidou D; Kalpidis I; Petsanis K; Dedousi E
Hell J Nucl Med; 2005; 8(1):39-42. PubMed ID: 15886752
[TBL] [Abstract][Full Text] [Related]
36. Investigative clinical study on prostate cancer part VI: Follicle-stimulating hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
Porcaro AB; Migliorini F; Petrozziello A; Sava T; Romano M; Caruso B; Cocco C; Ghimenton C; Zecchinini Antoniolli S; Lacola V; Rubilotta E; Monaco C; Comunale L
Urol Int; 2012; 88(2):150-7. PubMed ID: 22205171
[TBL] [Abstract][Full Text] [Related]
37. Serum FSH, LH, and testosterone concentrations in presumably fertile men: effect of age.
Tennekoon KH; Karunanayake EH
Int J Fertil; 1993; 38(2):108-12. PubMed ID: 8097499
[TBL] [Abstract][Full Text] [Related]
38. Experimental cryptorchidism in the adult mouse: II. A hormonal study.
Mendis-Handagama SM; Kerr JB; de Kretser DM
J Androl; 1990; 11(6):548-54. PubMed ID: 1982286
[TBL] [Abstract][Full Text] [Related]
39. [Reference values of FSH, LH, total testosterone, free testosterone, 17-beta-estradiol and SHBG in healthy children in Zaragoza].
Cortés Blanco A; Ferrández Longás A; Mayayo Dehesa E; Labarta Aizpún JI
An Esp Pediatr; 1999 Aug; 51(2):159-66. PubMed ID: 10495503
[TBL] [Abstract][Full Text] [Related]
40. Testosterone effects on luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the mouse.
Huang BM; Leu SF; Yang HY; Norman RL
J Androl; 2001; 22(3):507-13. PubMed ID: 11330652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
